Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa.

• मुख्य लेखकों: Robert A Harrison (लेखक), George O Oluoch (लेखक), Stuart Ainsworth (लेखक), Jaffer Alsolaiss (लेखक), Fiona Bolton (लेखक), Ana-Silvia Arias (लेखक), José-María Gutiérrez (लेखक), Paul Rowley (लेखक), Stephen Kalya (लेखक), Hastings Ozwara (लेखक), Nicholas R Casewell (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Public Library of Science (PLoS), 2017-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

<h4>Background</h4>Antivenom is the treatment of choice for snakebite, which annually kills an estimated 32,000 people in sub-Saharan Africa and leaves approximately 100,000 survivors with permanent physical disabilities that exert a considerable socioeconomic burden. Over the past two d...